Michael Westby

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)

Hans‐Jürgen Stellbrink, Jan van Lunzen, Michael Westby et al. · AIDS · 2002 · 121 citations

CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production.

J B Marriott, Michael Westby, Sharon Cookson et al. · PubMed · 1998 · 103 citations

Immunotoxicology, Potent Inhibitor, Immunology +22

CC-3052: A Water-Soluble Analog of Thalidomide and Potent Inhibitor of Activation-Induced TNF-α Production

J B Marriott, Michael Westby, Sharon Cookson et al. · The Journal of Immunology · 1998 · 86 citations · Full text

Immunotoxicology, Potent Inhibitor, Immunology +26

The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691)

Mark Fidock, B E Souberbielle, Carl Laxton et al. · Clinical Pharmacology & Therapeutics · 2011 · 70 citations

Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interkukin-2 in peripheral blood lymphocytes

Anthony Maraveyas, Babak Baban, D Kennard et al. · Annals of Oncology · 1999 · 67 citations · Full text

Cancer Immunosurveillance, Srl 172, Peripheral Blood Lymphocytes +9